UM  > 健康科學學院
Prevalence of overweight in schizophrenia patients in Asia: Findings of the research on Asian psychotropic prescription patterns (REAP) study
Wang F.8; Xiang Y.-T.8; Ungvari G.S.2; Ng C.H.1; Chiu H.F.K.5; Zheng W.4; Tan C.-H.3; Shinfuku N.7
2016-06-01
Source PublicationInternational Journal of Clinical Pharmacology and Therapeutics
ISSN09461965
Volume54Issue:6Pages:450-454
Abstract

Objective: This study examined the proportion of overweight in schizophrenia inpatients in selected Asian countries and territories and its independent demographic and clinical correlates. Method: Data on 1,534 hospitalized schizophrenia patients in 9 Asian countries and territories were collected by a review of medical files supplemented by a clinical interview during a 1-month period. Patients' sociodemographic and clinical characteristics, prescriptions of psychotropic drugs, and Body Mass Index (BMI) were recorded using a standardized protocol and data collection procedure. For analyzes, BMI ≥ 25 kg/m was defined as overweight. Results: The proportion of overweight was 35.8% (549/1,534) in the entire sample, with 39.7% (224/564) in females and 33.5% (325/970) in males (p = 0.01) and with wide inter-country variations. Multiple logistic regression analysis revealed that after controlling for study sites, overweight was independently associated with more frequent use of mood stabilizers (p < 0.001, odds ration (OR) = 1.4, 95% confidence interval (CI) = 1.1 - 1.8) and longer length of illness (p < 0.001, OR = 1.6, 95% CI = 1.2 - 2.1) but was less likely found in male patients (p = 0.003, OR = 0.7, 95% CI = 0.5 - 0.8). Conclusions: The prevalence of overweight Asian schizophrenia patients is significantly lower than the reported figures among their Western counterparts. There is considerable variation in prevalence of overweight schizophrenia patients within Asian countries and territories.

KeywordInpatients Overweight Psychotropic Medications Schizophrenia
DOI10.5414/CP202526
URLView the original
Indexed BySCI
Language英语
WOS Research AreaPharmacology & Pharmacy
WOS SubjectPharmacology & Pharmacy
WOS IDWOS:000377927400006
Fulltext Access
Citation statistics
Cited Times [WOS]:2   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionFaculty of Health Sciences
Affiliation1.University of Melbourne
2.University of Western Australia
3.National University of Singapore
4.Guangzhou Medical University
5.Chinese University of Hong Kong
6.University of Notre Dame Australia
7.Kobe University School of Medicine
8.Universidade de Macau
Recommended Citation
GB/T 7714
Wang F.,Xiang Y.-T.,Ungvari G.S.,et al. Prevalence of overweight in schizophrenia patients in Asia: Findings of the research on Asian psychotropic prescription patterns (REAP) study[J]. International Journal of Clinical Pharmacology and Therapeutics,2016,54(6):450-454.
APA Wang F..,Xiang Y.-T..,Ungvari G.S..,Ng C.H..,Chiu H.F.K..,...&Shinfuku N..(2016).Prevalence of overweight in schizophrenia patients in Asia: Findings of the research on Asian psychotropic prescription patterns (REAP) study.International Journal of Clinical Pharmacology and Therapeutics,54(6),450-454.
MLA Wang F.,et al."Prevalence of overweight in schizophrenia patients in Asia: Findings of the research on Asian psychotropic prescription patterns (REAP) study".International Journal of Clinical Pharmacology and Therapeutics 54.6(2016):450-454.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Wang F.]'s Articles
[Xiang Y.-T.]'s Articles
[Ungvari G.S.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Wang F.]'s Articles
[Xiang Y.-T.]'s Articles
[Ungvari G.S.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Wang F.]'s Articles
[Xiang Y.-T.]'s Articles
[Ungvari G.S.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.